Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2006; 12(33): 5336-5343
Published online Sep 7, 2006. doi: 10.3748/wjg.v12.i33.5336
Published online Sep 7, 2006. doi: 10.3748/wjg.v12.i33.5336
Table 2 Baseline biochemical parameters in gallstone patients (GS) and controls (mean ± SD)
| Biochemical parameter | GS (n = 10) | Controls (n = 10) | P |
| Serum creatinine (mg/dL) | 0.98 ± 0.25 | 0.96 ± 0.21 | NS |
| Blood nitrogen (mg/dL) | 39.4 ± 13.0 | 37.7 ± 10.6 | NS |
| AST (IU/I) | 23.2 ± 15.0 | 21.3 ± 12.7 | NS |
| ALT (IU/I) | 23.9 ± 14.6 | 21.8 ± 11.6 | NS |
| AP (IU/I) | 147.3 ± 63.2 | 150 ± 60.5 | NS |
| γGT (IU/I) | 28.0 ± 18.0 | 30.2 ± 15.8 | NS |
| Total proteins (g/dL) | 6.8 ± 0.57 | 6.9 ± 0.58 | NS |
| Total cholesterol (mg/dL) | 185.0 ± 38.5 | 178.4 ± 35 | NS |
| Fasting triglycerides (mg/dL) | 141.7 ± 30.8 | 138.5 ± 27.2 | NS |
| Fasting glucose (mg/dL) | 96.8 ± 12.0 | 95.3 ± 11.4 | NS |
- Citation: Colecchia A, Mazzella G, Sandri L, Azzaroli F, Magliuolo M, Simoni P, Bacchi-Reggiani M, Roda E, Festi D. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients. World J Gastroenterol 2006; 12(33): 5336-5343
- URL: https://www.wjgnet.com/1007-9327/full/v12/i33/5336.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i33.5336